---
schema_version: "secwatch.filing_event.v1"
accession: "0000899923-22-000112"
form_type: "8-K"
ticker: "MYGN"
cik: "0000899923"
company_name: "MYRIAD GENETICS INC"
filed_at: "2022-07-27T23:59:59+00:00"
generated_at: "2026-06-24T08:28:38.356270+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Myriad Genetics amends credit agreement: revolver cut to $200M, covenants waived through July 2023

## Summary
- Revolving commitments reduced from $300M to $200M, further to $150M by Dec 31, 2022; potential additional $50M cut from asset sales.
- Leverage ratio and interest coverage ratio covenants waived through July 31, 2023, the maturity date of the credit facility.
- Interest rate benchmark switched from LIBOR to SOFR; applicable margins and undrawn fees unchanged.
- Monthly liquidity reporting required if total revolving exposure > $0 (net of LC exposure under $5M).
- Lenders received a fee of 0.25% of their commitments for agreeing to the amendment.

## SEC filing metadata
- accession: 0000899923-22-000112
- form_type: 8-K
- ticker: MYGN
- cik: 0000899923
- company_name: MYRIAD GENETICS INC
- filed_at: 2022-07-27T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/899923/000089992322000112/0000899923-22-000112-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/899923/000089992322000112/mygn-20220726.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000899923-22-000112
- JSON: https://secwatch.observer/filing/0000899923-22-000112.json
- Plain text: https://secwatch.observer/filing/0000899923-22-000112.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.